Columbia, MO 的 大腸直腸癌 臨床試驗
7 項針對 大腸直腸癌 的研究正在 Columbia(約 30 英里範圍內)及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本(英文)
正在為研究招募對象嗎?將此頁面置頂展示 — $99 / 30 天 →
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
招募中2 期
- MU Health - University Hospital/Ellis Fischel Cancer Center, Columbia
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中觀察性研究歡迎健康志工
- MU Health - University Hospital/Ellis Fischel Cancer Center, Columbia
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
招募中3 期
- Missouri Cancer Associates, Columbia
A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)
招募中3 期
- Missouri Cancer Associates - 150518964, Columbia
A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)
招募中2 期
- Missouri Cancer Associates, Columbia
Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers
招募中觀察性研究歡迎健康志工
- Ellis Fischel Cancer Center, University of Missouri, Columbia
Tumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow
招募中觀察性研究歡迎健康志工
- Harry S Truman Veterans Memorial Hospital, Columbia
其他城市的 大腸直腸癌 試驗
- Houston, TX102 項研究
- New York City, NY78 項研究
- Nashville, TN69 項研究
- Boston, MA63 項研究
- Los Angeles, CA59 項研究
- Arlington, VA52 項研究
- St. Louis, MO50 項研究
- San Antonio, TX46 項研究
- Philadelphia, PA44 項研究
- Grand Rapids, MI40 項研究
- Baldwin Park, CA37 項研究
- Chicago, IL34 項研究
Columbia 的其他研究
- 肥胖症12 項研究
- 非小細胞肺癌8 項研究
- 重症肌無力6 項研究
- 癌症(所有類型)6 項研究
- 第二型糖尿病6 項研究
- 乳癌6 項研究
- 脂肪性肝病5 項研究
- 心臟衰竭5 項研究
- 心血管疾病5 項研究
- 肺癌5 項研究
- 腦出血4 項研究
- 高血壓4 項研究
資料來源:ClinicalTrials.gov,擷取日期 2026年10月6日。各研究自行設定資格標準;由研究團隊決定參與者資格。